Skip to main content
UTHR logo

UTHR · UNITED THERAPEUTICS Corp · Executive Compensation

Track UTHR — free
Market Cap
$25.18B
Shares
42.59M
Volume · Nov 16 165.24K Avg daily vol (3M) 700.23K

Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.

Fiscal 2019
Executive Total
Martine Rothblatt $15,627,537
Michael Benkowitz $8,383,194
Paul Mahon $7,564,551
James Edgemond $6,216,459
Fiscal 2018
Executive Total
Martine Rothblatt $16,036,300
Michael Benkowitz $6,609,258
Paul Mahon $5,297,542
James Edgemond $5,242,729
Fiscal 2017
Executive Total
Martine Rothblatt $17,933,401
Paul Mahon $6,871,506
Michael Benkowitz $6,517,529
James Edgemond $5,053,082

Executive changes

Person Change Filed
Victor Dzau, M.D. Appointed 2026-07-23
Kevin Tracey Appointed 2026-06-29
Tommy Thompson Appointed 2026-06-29
Louis Sullivan Appointed 2026-06-29
Christopher Patusky Appointed 2026-06-29
Martine Rothblatt Appointed 2026-06-29
Judy Olian Appointed 2026-06-29
Linda Maxwell Appointed 2026-06-29
Nilda Mesa Appointed 2026-06-29
Jan Malcolm Already on the board
Since at least 2024: re-election or new board role
2026-06-29
Ray Kurzweil Appointed 2026-06-29
Richard Giltner Appointed 2026-06-29
Christopher Causey Appointed 2026-06-29
Kevin J. Tracey Appointed 2026-01-22
Kevin J. Tracey, M.D. Appointed 2026-01-22
Tommy Thompson Appointed 2025-06-27
Louis Sullivan Appointed 2025-06-27
Martine Rothblatt Appointed 2025-06-27
Christopher Patusky Appointed 2025-06-27
Judy Olian Appointed 2025-06-27
Nilda Mesa Appointed 2025-06-27
Linda Maxwell Appointed 2025-06-27
Ray Kurzweil Appointed 2025-06-27
Jan Malcolm Appointed 2025-06-27
Richard Giltner Appointed 2025-06-27

Leadership

Key facts CIK 1082554 CUSIP 91307C102 13F (30d) 647 filings 596 filers Visit website Investor relations